ACCESSION: MSBNK-SMB_Measured-HSA015P0087003
RECORD_TITLE: Characterized; Piperazine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 30
COMMENT: RAW_SPEC {'Blanc1-pos_10952': {'bp': 95833.0, 'sum': 453728.0}, 'EL02_pos_10683': {'bp': 69378.0, 'sum': 262086.0}, 'EL22_pos_10781': {'bp': 67970.0, 'sum': 291646.0}, 'EL02_pos_10768': {'bp': 65423.0, 'sum': 308619.0}, 'EL05_pos_10769': {'bp': 61703.0, 'sum': 350514.0}, 'EL15_pos_10744': {'bp': 59015.0, 'sum': 271151.0}, 'EL21_pos_10727': {'bp': 57808.0, 'sum': 283552.0}, 'EL19_pos_10661': {'bp': 57744.0, 'sum': 258029.0}, 'EL17_pos_10719': {'bp': 56445.0, 'sum': 308060.0}, 'EL06_pos_10732': {'bp': 55947.0, 'sum': 275565.0}, 'EL05_pos_10577': {'bp': 54872.0, 'sum': 221783.0}, 'EL07_pos_10683': {'bp': 52005.0, 'sum': 234180.0}, 'EL14_pos_10708': {'bp': 51574.0, 'sum': 281800.0}, 'EL20_pos_10457': {'bp': 50713.0, 'sum': 195885.0}, 'EL01_pos_10605': {'bp': 50331.0, 'sum': 226911.0}, 'EL18_pos_10649': {'bp': 50149.0, 'sum': 222549.0}, 'EL17_pos_10607': {'bp': 49969.0, 'sum': 207283.0}, 'EL13_pos_10571': {'bp': 49949.0, 'sum': 219987.0}, 'EL07_pos_10486': {'bp': 49929.0, 'sum': 231951.0}, 'EL11_pos_10654': {'bp': 49201.0, 'sum': 214030.0}, 'EL08_pos_10631': {'bp': 49154.0, 'sum': 188509.0}, 'EL20_pos_10665': {'bp': 48105.0, 'sum': 261157.0}, 'EL13_pos_10673': {'bp': 46686.0, 'sum': 187895.0}, 'EL16_pos_10618': {'bp': 45372.0, 'sum': 209034.0}, 'EL10_pos_10643': {'bp': 45144.0, 'sum': 204350.0}, 'Blanc2-pos_10606': {'bp': 45111.0, 'sum': 259699.0}, 'Blanc3-pos_10587': {'bp': 44898.0, 'sum': 228491.0}, 'EL04_pos_10641': {'bp': 43374.0, 'sum': 249806.0}, 'EL14_pos_10611': {'bp': 41329.0, 'sum': 219276.0}, 'Blanc2-pos_10517': {'bp': 35633.0, 'sum': 172818.0}}
COMMENT: RETENTION_TIME_STDEV 0.111
COMMENT: PRECURSOR_M/Z_RAW 87.092334
COMMENT: PRECURSOR_M/Z_STDEV 0.000023
COMMENT: PRECURSOR_IN_MS1 mz 87.091672; int 38.381; delta(ppm) 0.461775
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 128.118430; int 25.055; cor 0.713
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 128.118430; int 25.055; cor 0.713
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 128.118430; int 25.055; cor 0.713
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.012; C4H10N2; [M+H]+; delta(ppm) -0.011617
COMMENT: PROPOSED_MF SevenGoldenRules 0.022; C2H7N; [M+ACN+H]+; delta(ppm) 0.022194
COMMENT: PROPOSED_MF MS-FINDER 3.184; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF MS-FINDER 2.222; C2H7N; [M+ACN+H]+; delta(ppm) 208461.893023
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.730; C2H7N; [M+C2H3N+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.730; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C2H7N; [M+C2H3N+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.478; C2H7N; [M+C2H3N+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.478; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C2H7N; [M+C2H3N+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.276; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; C1CNCC1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.244; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; C1CNCNC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.043; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; C1CCN(C1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.968; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; C1CNCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.895; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; CCCC(N)=N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.193; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.932; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.915; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.891; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.863; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.863; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.843; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.724; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.896; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.826; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.815; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.815; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.815; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.642; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.635; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.606; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.387; ROSDSFDQCJNGOL-UHFFFAOYSA-N; [M+ACN+H]+; N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.128; QUSNBJAOOMFDIB-UHFFFAOYSA-N; [M+ACN+H]+; ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.409; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.191; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; JYQKJYDDOGBPOA-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-1-methylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.117; HQFQTTNMBUPQAY-UHFFFAOYSA-N; [M+H]+; cyclobutylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.117; WKWPTGYQIHKPSJ-UHFFFAOYSA-N; [M+H]+; 2-methylprop-2-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; HBRZQKXSEKTPEW-UHFFFAOYSA-N; [M+H]+; but-3-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; FBFGFCAGFFHMPG-UHFFFAOYSA-N; [M+H]+; cyclopropylmethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; FPYGTMVTDDBHRP-OWOJBTEDSA-N; [M+H]+; (E)-but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; VMAXJDJIFGIBGH-UHFFFAOYSA-N; [M+H]+; azetidin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; MRYNEEIGLSDRKH-UHFFFAOYSA-N; [M+H]+; azetidin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; JATTWGKYNBEIMH-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; PRCGMIFKQRXNBS-UHFFFAOYSA-N; [M+H]+; 2-methylidenepropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; BIWZYRJXBPPLLA-UHFFFAOYSA-N; [M+H]+; 1-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.921; PYBBRDLRXFWWFU-UHFFFAOYSA-N; [M+H]+; 3-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.914; UYLSVYARXBFEKV-UHFFFAOYSA-N; [M+H]+; cyclobutane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; HTFFABIIOAKIBH-UHFFFAOYSA-N; [M+H]+; diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; VHCQWQAYVBRQQC-ZXZARUISSA-N; [M+H]+; (1R,2S)-cyclobutane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.818; SVKQJKDFMLYPSM-UHFFFAOYSA-N; [M+H]+; N'-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.818; NQPTWMKTGPWPMX-UHFFFAOYSA-N; [M+H]+; N-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.799; SPPFMFXKGYNRER-UHFFFAOYSA-N; [M+H]+; 4-methylpyrazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; MLTKZVHOZAKJMV-UHFFFAOYSA-N; [M+H]+; 3-ethyl-3-methyldiaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; PAXRVGDTBDATMF-UHFFFAOYSA-N; [M+H]+; N,N-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.447; JMHYNOCZNRXMLN-UHFFFAOYSA-N; [M+H]+; N,N'-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.257; INTMMHZKGCDQGT-UHFFFAOYSA-N; [M+H]+; diethyldiazene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; FDWQPDLACZBQBC-PLNGDYQASA-N; [M+H]+; N-[(Z)-ethylideneamino]-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -16.125; GLUUGHFHXGJENI; [M+H]+; Pipersol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -23.843; QUSNBJAOOMFDIB; [M+C2H3N+H]+; Ethamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -54.154; ROSDSFDQCJNGOL; [M+C2H3N+H]+; Dimethylamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -54.478; MRYNEEIGLSDRKH; [M+H]+; 2-Aminomethylazetidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.130; NGXSWUFDCSEIOO; [M+H]+; 3-Pyrrolidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.550; FPYGTMVTDDBHRP; [M+H]+; E-Bed diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.833; SBMSLRMNBSMKQC; [M+H]+; aminopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.999; JUDVCTHUDHRSSD; [M+H]+; 2-methylimidazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.761; INTMMHZKGCDQGT; [M+H]+; Azoaethan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.747; FDWQPDLACZBQBC; [M+H]+; Acetaldehyde dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.229; RXKUYBRRTKRGME; [M+H]+; Butyramidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.668; GLUUGHFHXGJENI; [M+H]+; Pipersol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -13.533; GLUUGHFHXGJENI; [M+H]+; piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -31.846; QUSNBJAOOMFDIB; [M+C2H3N+H]+; N,N,1,1,2-pentadeuterioethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.575; DKYBVKMIZODYKL; [M+H]+; Hexahydropyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -62.769; NGXSWUFDCSEIOO; [M+H]+; (S)-3-Aminopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.688; MRYNEEIGLSDRKH; [M+H]+; [(2R)-azetidin-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -86.975; ROSDSFDQCJNGOL; [M+C2H3N+H]+; hydron;N-methylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -96.017; FPYGTMVTDDBHRP; [M+H]+; 4-Azaniumylbut-2-enylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.402; ACPWGAXCVWNYSW; [M+H]+; But-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -110.929; WKWPTGYQIHKPSJ; [M+H]+; (2-Methylprop-2-en-1-yl)hydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.816; RXKUYBRRTKRGME; [M+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.175; KKGJQGHGLGXNII; [M+H]+; Dehydroputrescine (ambiguous)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.287; FDWQPDLACZBQBC; [M+H]+; Acetaldehyde dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.916; GLUUGHFHXGJENI; [M+H]+; piperazine
COMMENT: CONFIDENCE Level 3: Tentative candidate, Piperazine, GLUUGHFHXGJENI-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (4), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (6), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0014730;
CH$NAME: Piperazine
CH$NAME: piperazine
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H10N2
CH$EXACT_MASS: 86.084398
CH$SMILES: C1CNCCN1
CH$IUPAC: InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2
CH$LINK: CHEBI CHEBI:28568
CH$LINK: HMDB HMDB0014730
CH$LINK: INCHIKEY GLUUGHFHXGJENI-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:4837
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 17.361
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 87.091673
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-8f2241329319c8b15af8
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0497075 119.9288 56.050420 0.9813 24.91 0.5221 30 f{C3H6N1}/4.14ppm,p-C1H5N1
  58.0653654 200.8057 58.066086 0.7578 52.24 0.7575 30 f{C3H8N1}/4.13ppm,p-C1H3N1
  68.0495917 65.1845 68.050334 1.1315 21.54 0.7778 27 f{C4H6N1}/1.71ppm,p-H5N1
  70.0652607 624.4447 70.066004 0.4139 138.27 0.9293 30 f{C4H8N1}/1.93ppm,p-H3N1
  72.0444971 55.6762 72.045240 1.1382 14.70 0.2234 29 ?
  72.9981920 305.5317 72.998934 0.6439 30.10 0.3379 30 ?
  85.0760863 208.4382 85.076798 0.8816 76.33 0.9039 29 f{C4H9N2}/0.72ppm,p-H2
  86.0600845 275.3009 86.060791 0.8715 26.56 0.3575 30 ?
  87.0441286 76.2175 87.044831 1.3327 21.91 0.0224 28 ?
  87.0553854 81.4390 87.056087 0.8500 19.62 0.6650 23 ?
  87.0917065 361.2316 87.092408 0.5971 139.53 1.0000 30 f{C4H11N2}/0.36ppm,p
  88.0215839 999.0000 88.022281 0.3749 0.00 0.2974 30 ?
  88.0757239 763.9991 88.076421 0.3293 72.99 0.2610 30 ?
  88.1120908 53.9080 88.112787 1.3846 13.84 0.0593 23 ?
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  56.049707 119.93 119
  58.065365 200.81 200
  68.049592 65.18 65
  70.065261 624.44 624
  72.044497 55.68 55
  72.998192 305.53 305
  85.076086 208.44 208
  86.060085 275.30 275
  87.044129 76.22 76
  87.055385 81.44 81
  87.091706 361.23 361
  88.021584 999.00 999
  88.075724 764.00 763
  88.112091 53.91 53
//
